GR1008143B - Pharmaceutical preparation containing one oxazolidinonic antibacterial factor-preparation method of the same - Google Patents

Pharmaceutical preparation containing one oxazolidinonic antibacterial factor-preparation method of the same

Info

Publication number
GR1008143B
GR1008143B GR20130100147A GR20130100147A GR1008143B GR 1008143 B GR1008143 B GR 1008143B GR 20130100147 A GR20130100147 A GR 20130100147A GR 20130100147 A GR20130100147 A GR 20130100147A GR 1008143 B GR1008143 B GR 1008143B
Authority
GR
Greece
Prior art keywords
preparation
oxazolidinonic
same
antibacterial factor
pharmaceutical preparation
Prior art date
Application number
GR20130100147A
Other languages
Greek (el)
Inventor
Ευθυμιος Χρηστου Κουτρης
Ιωαννα Χρηστου Κουτρη
Αθηνα Γεωργιου Ηλιοπουλου
Αναστασια Λεωνιδα Καλασκανη
Βασιλικη Χρηστου Σαμαρα
Μορφης Νικολαου Αμπατζης
Ευαγγελος Ανδρεα Καραβας
Χριστινα Κιριζιδη
Original Assignee
"Φαρματεν Α.Β.Ε.Ε.",
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Φαρματεν Α.Β.Ε.Ε.", filed Critical "Φαρματεν Α.Β.Ε.Ε.",
Priority to GR20130100147A priority Critical patent/GR1008143B/en
Priority to EP14711148.8A priority patent/EP2968170A1/en
Priority to PCT/EP2014/000605 priority patent/WO2014139657A1/en
Publication of GR1008143B publication Critical patent/GR1008143B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Abstract

The present preparation relates to a solid orally-administrated pharmaceutical form composed of the theurapetic drastic quantity of an antibacterial factor of oxazolidinone and more precisely of linezolid having particles (D90) with size less than 75μm and being characterised by physical and chemical stability. There is also disclosed herein the preparation method of the aforementioned preparation.
GR20130100147A 2013-03-11 2013-03-11 Pharmaceutical preparation containing one oxazolidinonic antibacterial factor-preparation method of the same GR1008143B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GR20130100147A GR1008143B (en) 2013-03-11 2013-03-11 Pharmaceutical preparation containing one oxazolidinonic antibacterial factor-preparation method of the same
EP14711148.8A EP2968170A1 (en) 2013-03-11 2014-03-10 Pharmaceutical composition containing an oxazolidinone antibacterial agent and method for the preparation thereof
PCT/EP2014/000605 WO2014139657A1 (en) 2013-03-11 2014-03-10 Pharmaceutical composition containing an oxazolidinone antibacterial agent and method for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20130100147A GR1008143B (en) 2013-03-11 2013-03-11 Pharmaceutical preparation containing one oxazolidinonic antibacterial factor-preparation method of the same

Publications (1)

Publication Number Publication Date
GR1008143B true GR1008143B (en) 2014-03-14

Family

ID=50336255

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20130100147A GR1008143B (en) 2013-03-11 2013-03-11 Pharmaceutical preparation containing one oxazolidinonic antibacterial factor-preparation method of the same

Country Status (3)

Country Link
EP (1) EP2968170A1 (en)
GR (1) GR1008143B (en)
WO (1) WO2014139657A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451345B1 (en) 2000-01-20 2002-09-17 Eurand Pharmaceuticals Ltd. Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
PE20020578A1 (en) * 2000-10-10 2002-08-14 Upjohn Co A TOPICAL ANTIBIOTIC COMPOSITION FOR THE TREATMENT OF EYE INFECTIONS
WO2006008640A1 (en) * 2004-07-15 2006-01-26 Pharmacia & Upjohn Company Llc Non-aqueous suspension containing a drug having an unpleasant taste
WO2007102082A1 (en) * 2006-03-09 2007-09-13 Glenmark Pharmaceuticals Limited High oxazolidinone content solid dosage forms
WO2010026597A1 (en) 2008-09-02 2010-03-11 Hetero Research Foundation Oral dosage forms of linezolid and processes for their preparation
CN102885788B (en) * 2011-07-22 2016-06-29 重庆华邦制药有限公司 A kind of Linezolid sheet of stable crystal form and preparation method thereof

Also Published As

Publication number Publication date
EP2968170A1 (en) 2016-01-20
WO2014139657A1 (en) 2014-09-18

Similar Documents

Publication Publication Date Title
PH12016501236A1 (en) Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine
MY185221A (en) New thienopyrimidine derivatives, a process for their preparation and pharmaceutical compositions containing them
IL243277B (en) Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
PH12015501996A1 (en) Heterocyclic compounds and uses thereof
MY173258A (en) New phosphate compounds, a process for their preparation and pharmaceutical compositions containing them
MY173259A (en) New pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
PH12016500057B1 (en) Novel indolizine compounds, a process for their preparation and pharmaceutical compositions containing them
EP3036231A4 (en) Substituted pyrimidine compounds, compositions and medicinal applications thereof
EA201590405A1 (en) PREPARATION OF DRIED LIPOS FOR APPLICATION IN THE SYSTEMS OF THE ISSUE IN A PRESSED TYPE
HK1221923A1 (en) Pen type drug injection device with dose limiting nut to prevent setting of a dose higher than the amount of drug remaining
MY180788A (en) Paste for internal electrode of laminated ceramic capacitor, and laminated ceramic capacitor
MA40313A (en) Oral pharmaceutical composition of isotretinoin
MX2014014868A (en) Process for producing cell culture media.
IL237688A0 (en) Syringe containing a composition, especially a pharmaceutical composition, comprising immunoglobins, methods for the production thereof and use of same
PH12014501840A1 (en) Pharmaceutical formulation having improved stability
MX2012014970A (en) Pharmaceutical compositions comprising ezetimibe and novel amorphous rosuvastatin calcium.
GR1008143B (en) Pharmaceutical preparation containing one oxazolidinonic antibacterial factor-preparation method of the same
HUP1600414A2 (en) Stable pharmaceutical composition containing bisoprolol and ramipril
EA201500313A1 (en) STABILIZED AMORPHOUS FORM OF AGOMELATIN, THE WAY OF ITS MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS, ITS CONTAINING
PH12017500323A1 (en) P38 map kinase inhibiting indanyl urea compounds
PH12016501245A1 (en) Stable and palatable liquid pharmaceutical composition of phenylephrine and a maleate salt of an antihistamine
IN2014KN01768A (en)
MX364541B (en) Film forming containing compositions comprising polyvinyl acetate and a pigment.
UA85352U (en) Pharmaceutical composition containing nalbufin
ZA201304500B (en) Intravenous frmulation of linezolid and method for preparation thereof

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20140416